Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

RecruitingOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

September 3, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Type 2 DiabetesType 2 Diabetes Mellitus (T2DM)T2DM (Type 2 Diabetes Mellitus)T2DT2DMRemote Patient MonitoringArtificial Intelegence
Interventions
BEHAVIORAL

Fitbit and AI Chatbot

Participants will wear their Fitbit devices daily for 12-weeks and will receive personalized messages from the AI Chatbot every week with a new exercise recommendation based on their previous week's activity level. Additionally, they can engage with the AI Chatbot through text message for further support and education.

OTHER

Routine Care

The control group will consist of patients with type 2 diabetes who meet the study's inclusion criteria but have not participated in the intervention.

Trial Locations (1)

80045

RECRUITING

University of Colorado, Anschutz, Aurora

All Listed Sponsors
collaborator

American Academy of Family Physicians

OTHER

lead

University of Colorado, Denver

OTHER